How and Where to Find NPS Users: a Comparison of Methods in a Cross-National Survey Among Three Groups of Current Users of New Psychoactive Substances in Europe

Author:

Korf Dirk,Benschop Annemieke,Werse Bernd,Kamphausen Gerrit,Felvinczi Katalin,Dąbrowska Katarzyna,Hernriques Susana,Nabben Ton,Wieczorek Łukasz,Bujalski Michał,Kalo Zsusza,Hearne Evelyn,Van Hout Marie Claire

Abstract

AbstractUse of new psychoactive substances (NPS) across Europe remains a public health challenge. The study describes potentials and limitations of methods in a transnational survey of recent marginalised, nightlife and online community NPS users in Germany, Hungary, Ireland, the Netherlands, Poland and Portugal (n = 3023). In terms of demographic profile, drug use history and type of NPS, different methods reached different segments of the NPS-using population. Last year use of different NPS varied across countries and groups. Respondents used NPS in a variety of settings, with public spaces most common in the marginalised group. The study suggests that prevalence rates can reveal a picture of the NPS market that significantly deviates from what law enforcement seizures indicate. Outreach in nightlife settings and peer education are recommended to inform users about health risks and to improve access to drug services and care.

Funder

European Commission, DG Justice

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Reference25 articles.

1. Carhart-Harris, R. L., King, L. A., & Nutt, D. (2011). A web-based survey on mephedrone. Drug and Alcohol Dependence, 11(1), 19–22.

2. Dabrowaska, K., & Bujalski, M. (2013). The legal highs problem in the Polish printed media—actors, claims and its hidden meanings. Substance Use & Misuse, 48(1–2), 31–40. https://doi.org/10.3109/10826084.2012.720336.

3. EMCDDA. (2014). European drug report 2014: trends and development. Lisbon: EMCDDA.

4. EMCDDA. (2016). New psychoactive substances in Europe: legislation and prosecution—current challenges and solutions. Lisbon: EMCDDA.

5. EMCDDA. (2017a). High-risk drug use and new psychoactive substances. In Results from an EMCDDA trendspotter study. Lisbon: EMCDDA.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3